In four pre-registered studies across Belgium, the US, and the UK, people judged anti-obesity medication users as putting in ...

Ozempic and other GLP-1-based drugs are a major advancement in obesity treatment, but they are not free of side effects, and ...

Many patients taking glucagon-like peptide-1 (GLP-1) receptor agonists have reported psychological benefits alongside reduced ...

Semaglutide and tirzepatide telehealth access, compounded GLP-1 program pricing, refund terms, and weight loss medication ...

Drugmakers continue to test weight-loss medicines against dummy pills and shots, even with a growing number of effective approved obesity drugs. This practice raises practical questions.

Online personalities and individual social media users have for years hawked yerba mate and fiber products as methods to ...

As next generation antiobesity medications (AOMs) take the culture by storm, many providers and researchers are asking an important question: how are distinct subsets of the population differently ...

Scientists have discovered natural GLP-1 in joint fluid, which could open up a new treatment option for arthritis.

Social media posts about glucagon-like peptide-1 receptor agonists may identify patient concerns not captured in clinical trials.

Injectable weight loss and diabetes therapies continue to thrive despite recent oral GLP-1 drug approvals. Experts said they ...

New meta-analysis data suggest that temporary intragastric devices significantly improve liver morphology and biochemical ...

As many of us know, keeping weight in check can be hard. National data reflect that reality. Rates of overweight and obesity in the U.S. have steadily climbed since the early 1980s. The impact on ...